Cargando…
Management Challenges of Deep Infiltrating Endometriosis
Deep infiltrating endometriosis (DIE) is the most aggressive of the three phenotypes that constitute endometriosis. It can affect the whole pelvis, subverting the anatomy and functionality of vital organs, with an important negative impact on the patient’s quality of life. The diagnosis of DIE is ba...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052801/ https://www.ncbi.nlm.nih.gov/pubmed/33687160 http://dx.doi.org/10.22074/IJFS.2020.134689 |
_version_ | 1783679997481844736 |
---|---|
author | D’Alterio, Maurizio Nicola D’Ancona, Gianmarco Raslan, Mohamed Tinelli, Raffaele Daniilidis, Angelos Angioni, Stefano |
author_facet | D’Alterio, Maurizio Nicola D’Ancona, Gianmarco Raslan, Mohamed Tinelli, Raffaele Daniilidis, Angelos Angioni, Stefano |
author_sort | D’Alterio, Maurizio Nicola |
collection | PubMed |
description | Deep infiltrating endometriosis (DIE) is the most aggressive of the three phenotypes that constitute endometriosis. It can affect the whole pelvis, subverting the anatomy and functionality of vital organs, with an important negative impact on the patient’s quality of life. The diagnosis of DIE is based on clinical and physical examination, instrumen- tal examination, and, if surgery is needed, the identification and biopsy of lesions. The choice of the best therapeutic approach for women with DIE is often challenging. Therapeutic options include medical and surgical treatment, and the decision should be dictated by the patient’s medical history, disease stage, symptom severity, and personal choice. Medical therapy can control the symptoms and stop the development of pathology, keeping in mind the side effects derived from a long-term treatment and the risk of recurrence once suspended. Surgical treatment should be proposed only when it is strictly necessary (failed hormone therapy, contraindications to hormone treatment, severity of symp- toms, infertility), preferring, whenever possible, a conservative approach performed by a multidisciplinary team. All therapeutic possibilities have to be explained by the physicians in order to help the patients to make the right choice and minimize the impact of the disease on their lives. |
format | Online Article Text |
id | pubmed-8052801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Royan Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-80528012021-04-21 Management Challenges of Deep Infiltrating Endometriosis D’Alterio, Maurizio Nicola D’Ancona, Gianmarco Raslan, Mohamed Tinelli, Raffaele Daniilidis, Angelos Angioni, Stefano Int J Fertil Steril Original Article Deep infiltrating endometriosis (DIE) is the most aggressive of the three phenotypes that constitute endometriosis. It can affect the whole pelvis, subverting the anatomy and functionality of vital organs, with an important negative impact on the patient’s quality of life. The diagnosis of DIE is based on clinical and physical examination, instrumen- tal examination, and, if surgery is needed, the identification and biopsy of lesions. The choice of the best therapeutic approach for women with DIE is often challenging. Therapeutic options include medical and surgical treatment, and the decision should be dictated by the patient’s medical history, disease stage, symptom severity, and personal choice. Medical therapy can control the symptoms and stop the development of pathology, keeping in mind the side effects derived from a long-term treatment and the risk of recurrence once suspended. Surgical treatment should be proposed only when it is strictly necessary (failed hormone therapy, contraindications to hormone treatment, severity of symp- toms, infertility), preferring, whenever possible, a conservative approach performed by a multidisciplinary team. All therapeutic possibilities have to be explained by the physicians in order to help the patients to make the right choice and minimize the impact of the disease on their lives. Royan Institute 2021 2021-03-11 /pmc/articles/PMC8052801/ /pubmed/33687160 http://dx.doi.org/10.22074/IJFS.2020.134689 Text en The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited. https://creativecommons.org/licenses/by/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article D’Alterio, Maurizio Nicola D’Ancona, Gianmarco Raslan, Mohamed Tinelli, Raffaele Daniilidis, Angelos Angioni, Stefano Management Challenges of Deep Infiltrating Endometriosis |
title | Management Challenges of Deep Infiltrating Endometriosis |
title_full | Management Challenges of Deep Infiltrating Endometriosis |
title_fullStr | Management Challenges of Deep Infiltrating Endometriosis |
title_full_unstemmed | Management Challenges of Deep Infiltrating Endometriosis |
title_short | Management Challenges of Deep Infiltrating Endometriosis |
title_sort | management challenges of deep infiltrating endometriosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052801/ https://www.ncbi.nlm.nih.gov/pubmed/33687160 http://dx.doi.org/10.22074/IJFS.2020.134689 |
work_keys_str_mv | AT dalteriomaurizionicola managementchallengesofdeepinfiltratingendometriosis AT danconagianmarco managementchallengesofdeepinfiltratingendometriosis AT raslanmohamed managementchallengesofdeepinfiltratingendometriosis AT tinelliraffaele managementchallengesofdeepinfiltratingendometriosis AT daniilidisangelos managementchallengesofdeepinfiltratingendometriosis AT angionistefano managementchallengesofdeepinfiltratingendometriosis |